1. Sustained viral suppression with dolutegravir monotherapy in a treatment-experienced adult with perinatally acquired HIV.
- Author
-
Koay WLA, Sadler ED, Ferrer K, and Rakhmanina NY
- Subjects
- Female, Heterocyclic Compounds, 3-Ring, Humans, Oxazines therapeutic use, Piperazines therapeutic use, Pyridones therapeutic use, Sustained Virologic Response, Viral Load, HIV Infections drug therapy, HIV Integrase Inhibitors therapeutic use
- Abstract
We report a case of sustained viral suppression with dolutegravir monotherapy in a treatment-experienced adult with perinatally acquired HIV. The patient had recurrent pancreatitis with multiple antiretroviral drugs, leading to discontinuation of antiretroviral therapy for several years. She was ultimately initiated on dolutegravir monotherapy two times per day via a gastrostomy tube. She did not develop any integrase strand transfer inhibitor mutations during the first 2 years on dolutegravir monotherapy. The patient has successfully maintained prolonged viral suppression for over 3 years with intermittent blips secondary only to intermittent medical issues. This case is unique in describing a highly treatment-experienced young adult with perinatal HIV infection who has been virally suppressed on dolutegravir monotherapy for a prolonged follow-up of 156 weeks., Competing Interests: Competing interests: None declared., (© BMJ Publishing Group Limited 2021. No commercial re-use. See rights and permissions. Published by BMJ.)
- Published
- 2021
- Full Text
- View/download PDF